Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy

Producció científica: Contribució a una revista › Article › Recerca › Avaluat per experts

4 Cites (Scopus)

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

@article{82edce17ccdb4898a110ebeb3e7cc4c0,

title = "Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy",

keywords = "Hepatitis B, Tenofovir alafenomide (TAF), Therapy",

author = "Maria Buti and Mar Riveiro-Barciela and Rafael Esteban",

year = "2021",

month = nov,

doi = "10.1016/j.cld.2021.06.003",

language = "English",

volume = "25",

pages = "725--740",

journal = "Clinics in Liver Disease",

issn = "1089-3261",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy

AU - Buti, Maria

AU - Riveiro-Barciela, Mar

AU - Esteban, Rafael

PY - 2021/11

Y1 - 2021/11

KW - Hepatitis B

KW - Tenofovir alafenomide (TAF)

KW - Therapy

U2 - 10.1016/j.cld.2021.06.003

DO - 10.1016/j.cld.2021.06.003

M3 - Article

SN - 1089-3261

VL - 25

SP - 725

EP - 740

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

IS - 4

ER -